Company Filing History:
Years Active: 2019-2023
Title: Innovator Patrizia Caposio: Pioneering Research in Human Cytomegalovirus
Introduction
Patrizia Caposio is a distinguished inventor based in Beaverton, Oregon. She has made significant contributions to the field of virology, particularly in the study of human cytomegalovirus (HCMV). With a total of 3 patents to her name, her work has implications for vaccine development and therapeutic strategies.
Latest Patents
Among her latest patents, Patrizia has developed innovative human cytomegalovirus vectors that comprise exogenous antigens. These vectors, derived from the TR strain, are ganciclovir-sensitive and include active genes such as US2, US3, US6, US7, and UL131A. Notably, they also feature a deleterious or inactivating mutation in the UL82 gene, which prevents the expression of pp71. This groundbreaking research has the potential to enhance our understanding of HCMV and its interactions with the immune system.
Career Highlights
Patrizia Caposio is affiliated with Oregon Health & Science University, where she conducts her research. Her work has garnered attention for its innovative approach to tackling viral infections. She has established herself as a key figure in her field, contributing to advancements that could lead to improved health outcomes.
Collaborations
Throughout her career, Patrizia has collaborated with notable colleagues, including Klaus Frueh and Scott G. Hansen. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Patrizia Caposio's contributions to the field of virology, particularly through her patents on human cytomegalovirus, highlight her role as an influential inventor. Her ongoing research continues to pave the way for advancements in medical science.